COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,912 Articles (22,044 medRxiv, 7,868 bioRxiv)

Most recent first Previous |  Page 2942: Articles 29411-29420  | Next

Estimation of instant case fatality rate of COVID-19 in Wuhan and Hubei based on daily case notification data
Cao, L., Huang, T.-t., Zhang, J.-x., Qin, Q., Liu, S.-y., Xue, H.-m., Gong, Y.-x., Ning, C.-h., Shen, X.-t., Yang, J.-x., Mi, Y.-n., Xiao, X., Cao, Y.
10.1101/2020.03.11.20034215 — Posted: 2020-03-13
Virus strain of a mild COVID-19 patient in Hangzhou representing a new trend in SARS-CoV-2 evolution related to Furin cleavage site
Xi, J., Xu, K., Jiang, P., Lian, J., Hao, S., Jia, H., Yao, H., Zhang, Y., Zheng, R., Chen, D., Yao, J., Hu, J., Gao, J., Shen, J., Wen, L., Ren, Y., Yu, G., Wang, X., Lu, Y., Yu, X., Yu, L., Xiang, D., Zheng, L., Wu, N., Lu, X., Cheng, L., Liu, F., Wu, H., Jin, C., Yang, X., Qian, P., Qiu, Y., Sheng, J., Liang, T., Li, L., Yang, Y.
10.1101/2020.03.10.20033944 — Posted: 2020-03-13 Discussion: Onsite
Prediction of the COVID-19 outbreak based on a realistic stochastic model
Zhang, Y., You, C., Cai, Z., Sun, J., Hu, W., Zhou, X.-H.
10.1101/2020.03.10.20033803 — Posted: 2020-03-13
Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19
Chen, J., Fan, H., Zhang, L., Huang, B., Zhu, M., Zhou, Y., Yu, W., Zhu, L., Cheng, S., Tao, X., Zhang, H.
10.1101/2020.03.09.20033068 — Posted: 2020-03-12 Discussion: Onsite
First 12 patients with coronavirus disease 2019 (COVID-19) in the United States
Kujawski, S. A., Wong, K. K., Collins, J. P., Epstein, L., Killerby, M. E., Midgley, C. M., Abedi, G. R., Ahmed, N. S., Almendares, O., Alvarez, F. N., Anderson, K. N., Balter, S., Barry, V., Bartlett, K., Beer, K., Ben-Aderet, M. A., Benowitz, I., Biggs, H., Binder, A. M., Black, S. R., Bonin, B., Brown, C. M., Bruce, H., Bryant-Genevier, J., Budd, A., Buell, D., Bystritsky, R., Cates, J., Charles, E. M., Chatham-Stephens, K., Chea, N., Chiou, H., Christiansen, D., Chu, V., Cody, S., Cohen, M., Conners, E., Curns, A., Dasari, V., Dawson, P., DeSalvo, T., Diaz, G., Donahue, M., Donovan, S., Duca, L. M., Erickson, K., Esona, M. D., Evans, S., Falk, J., Feldstein, L. R., Fenstersheib, M., Fischer, M., Fisher, R., Foo, C., Fricchione, M. J., Friedman, O., Fry, A. M., Galang, R. R., Garcia, M. M., Gerber, S. I., Gerrard, G., Ghinai, I., Gounder, P., Grein, J., Grigg, C., Gunzenhauser, J. D., Gutkin, G. I., Haddix, M., Hall, A. J., Han, G., Harcourt, J., Harriman, K., Haupt, T., Haynes, A., Holshue, M., Hoover, C., Hunter, J. C., Jacobs, M. W., Jarashow, C., Jhung, M. A., Joshi, K., Kamali, T., Kamili, S., Kim, L., Kim, M., King, J., Kirking, H. L., Kita-Yarbro, A., Klos, R., Kobayashi, M., Kocharian, A., Komatsu, K. K., Koppaka, R., Layden, J. E., Li, Y., Lindquist, S., Lindstrom, S., Link-Gelles, R., Lively, J., Livingston, M., Lo, K., Lo, J., Lu, X., Lynch, B., Madoff, L., Malapati, L., Marks, G., Marlow, M., Mathisen, G. E., McClung, N., McGovern, O., McPherson, T. D., Mehta, M., Meier, A., Mello, L., Moon, S., Morgan, M., Moro, R. N., Murray, J., Murthy, R., Novosad, S., Oliver, S. E., O'Shea, J., Pacilli, M., Paden, C. R., Pallansch, M. A., Patel, M., Patel, S., Pedraza, I., Pillai, S. K., Pindyck, T., Pray, I., Queen, K., Quick, N., Reese, H., Rha, B., Rhodes, H., Robinson, S., Robinson, P., Rolfes, M., Routh, J., Rubin, R., Rudman, S. L., Sakthivel, S. K., Scott, S., Shepherd, C., Shetty, V., Smith, E. A., Smith, S., Stierman, B., Stoecker, W., Sunenshine, R., Sy-Santos, R., Tamin, A., Tao, Y., Terashita, D., Thornburg, N. J., Tong, S., Traub, E., Tural, A., Uehara, A., Uyeki, T. M., Vahey, G., Verani, J. R., Villarino, E., Wallace, M., Wang, L., Watson, J. T., Westercamp, M., Whitaker, B., Wilkerson, S., Woodruff, R. C., Wortham, J. M., Wu, T., Xie, A., Yousaf, A., Zahn, M., Zhang, J.
10.1101/2020.03.09.20032896 — Posted: 2020-03-12
The effect of control strategies that reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China
Prem, K., Liu, Y., Russell, T., Kucharski, A. J., Eggo, R. M., Davies, N., Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group, , Jit, M., Klepac, P.
10.1101/2020.03.09.20033050 — Posted: 2020-03-12
Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults
Liao, J., Fan, S., Chen, J., Wu, J., Xu, S., Guo, Y., Li, C., Zhang, X., Wu, C., Mou, H., Song, C., Li, F., Wu, G., Zhang, J., Guo, L., Liu, H., Lv, J., Xu, L., Lang, C.
10.1101/2020.03.10.20032136 — Posted: 2020-03-12
Effects of Chinese strategies for controlling the diffusion and deterioration of novel coronavirus-infected pneumonia in China
Wang, X., Tian, W., Lv, X., Shi, Y., Zhou, X., Yu, W., Su, D., Tian, J.
10.1101/2020.03.10.20032755 — Posted: 2020-03-12
Quantifying dynamics of SARS-CoV-2 transmission suggests that epidemic control and avoidance is feasible through instantaneous digital contact tracing
Ferretti, L., Wymant, C., Kendall, M., Zhao, L., Nurtay, A., Bonsall, D. G., Fraser, C.
10.1101/2020.03.08.20032946 — Posted: 2020-03-12
The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China.
Costantino, V., Heslop, D. J., MacIntyre, C. R.
10.1101/2020.03.09.20032045 — Posted: 2020-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).